Phio Pharmaceuticals Corp.
REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
Last updated:
Abstract:
The present invention relates to RNAi constructs with minimal double-stranded regions, and their use in gene silencing. RNAi constructs associated with the invention include a double stranded region of 8-14 nucleotides and a variety of chemical modifications, and are highly effective in gene silencing.
Status:
Application
Type:
Utility
Filling date:
21 Jul 2020
Issue date:
20 May 2021